Key Financial Data Of Reporting Company

K Pharma,Inc. - Filing #7538109

Concept As at
2023-09-30
2023-01-01 to
2023-09-30
2023-07-01 to
2023-09-30
2022-01-01 to
2022-12-31
As at
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,000,000,000 JPY
JPY
Ordinary profit (loss)
508,569,000 JPY
-359,233,000 JPY
Profit (loss)
398,213,000 JPY
-392,427,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
Share capital
100,000,000 JPY
100,000,000 JPY
Total number of issued shares
9,879,000 xbrli:shares
5,000 xbrli:shares
Net assets
1,734,476,000 JPY
1,336,263,000 JPY
Total assets
1,981,662,000 JPY
1,374,566,000 JPY
Dividend paid per share
Basic earnings (loss) per share
40.31
-11.80
-42.06
Diluted earnings per share
Equity-to-asset ratio
0.875 xbrli:pure
0.972 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.